The regulation of 17,20 lyase activity

Steroids

Volumn 62, Issue 1, 1997, Pages 133-142

  Miller, Walter L ^a,b   Auchus, Richard J ^a   Geller, David H ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

17 hydroxylase; adrenarche; molecular modeling; P450c17; serine phosphorylation; sex steroid

Indexed keywords

STEROID 17,20 LYASE;

ADRENARCHE; CONFERENCE PAPER; ENZYME ACTIVITY; ENZYME REGULATION; MICROSOME; NONHUMAN; OXIDATION REDUCTION REACTION; STEROIDOGENESIS;

EID: 0031032651     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(96)00172-9     Document Type: Conference Paper

References (77)

1. Miller WL (1988). Molecular biology of steroid hormone synthesis. Endocr Rev 9:295-318.
2. Fardella CE, Miller WL (1996). Molecular biology of mineralocorticoid metabolism. Annu Rev Nutr 16:443-470.
3. 17,21 lyase). J Biol Chem 256:3871-3876.
4. Nakajin S, Shively JE, Yuan P, Hall PF (1981). Microsomal cytochrome P450 from neonatal pig testis: two enzymatic activities (17α-hydroxylase and C17,20-lyase) associated with one protein. Biochemistry 20:4037-4042.
5. 17,20 lyase cytochrome P450. J Biol Chem 259:3971-3976.
6. 17,20 bond cleavage from guinea pig adrenal microsomes. Biochem Biophys Res Commun 109:916-921.
7. Suhara K, Fujimura Y, Shiroo M, Katagiri M (1984). Multiple catalytic properties of the purified and reconstituted cytochrome P-450 (P-450sccII) system of pig testis microsomes. J Biol Chem 259: 8729-8736.
8. Zuber MX, John ME, Okamura T, Simpson ER, Waterman MR (1986). Bovine adrenal cytochrome P45017: regulation of gene expression by ACTH and eludication of primary sequence. J Biol Chem 261:2475-2782.
9. 106 → Pro causes 17α-hydroxylase deficiency. J Biol Chem 266:15992-15998.
10. Homsby PJ, Yang L, Raju SG, Maghsoudlou SS, Lala DS, Nallaseth FS (1992). Demethylation of specific sites in the 5′-flanking region of the CYP17 genes when bovine adrenocortical cells are placed in culture. DNA Cell Biol 11:385-395.
11. Chung B, Picado-Leonard J, Haniu M, Bienkowski M, Hall PF, Shivley JE, Miller WL (1987). Cytochrome P450c17 (steroid 17α - hydroxylase/17,20 lyase): cloning of human adrenal and testis cDNAs indicates the same gene is expressed in both tissues. Proc Natl Acad Sci USA 84:407-411.
12. Picado-Leonard J, Miller WL (1987). Cloning and sequence of the human gene encoding P450c17 (steroid 17α-hydroxylase/17,20 lyase): similarity to the gene for P450c21. DNA 6:439-448.
13. Kagimoto M, Winter JS, Kagimoto K, Simpson ER, Waterman MR (1988). Structural characterization of normal and mutant human steroid 17-alpha-hydroxylase genes: molecular basis of one example of combiend 17-alpha-hydroxylase/17,20 lyase deficiency. Mol Endocrinol 2:564-570.
14. Matteson KJ, Picado-Leonard J, Chung B, Mohandas TK, Miller WL (1986). Assignment of the gene for adrenal P450c17 (17α-hydroxylase/17,20 lyase) to human chromosome 10. J Clin Endocrinol Metab 63:789-791.
15. Sparkes RS, Klisak I, Miller WL (1991). Regional mapping of genes encoding human steroidogenic enzymes: P450scc to 15q23-q24, adrenodoxin to 11q22; adrenodoxin reductase to 17q24-q25; and P450c17 to 10q24-q25. DNA Cell Biol 10:359-365.
16. Fan YS, Sasi R, Lee C, Winter JSD, Waterman MR, Lin CC (1992). Localization of the human CYP17 gene (cytochrome P450 17α to 10q24.3) by fluorescence in situ hybridization and simultaneous chromosome banding. Genomics 14:1110-1111.
17. Fardella CE, Hum DW, Homoki J, Miller WL (1994). Point mutation Arg440 to His in cytochrome P450c17 causes severe 17α-hydroxylase deficiency. J Clin Endocrinol Metab 79:160-164.
18. Yanase T (1995). 17α-Hydroxylase/17,20 lyase defects. J Steroid Biochem 53:153-157.
19. LaFlamme N, Leblanc J, Mailloux J, Faure N, Labrie F, Simard J (1996). Mutation R96W in cytochrome P450c17 gene causes combined 17α-hydroxyl/17,20 lyase deficiency in two French Canadian patients. J Clin Endocrinol Metab 81:264-268.
20. Zachman M, Vollmin JA, Hamilton W, Prader A (1972). Steroid 17,20 desmolase deficiency: a new cause of male pseudohermaphroditism. Clin Endocrinol 1:369-385.
21. Zachman M, Werder EA, Prader A (1982). Two types of male pseucohermaphroditism due to 17,20 desmolase deficiency. J Clin Endocrinol Metab 55:487-490.
22. Goebelsmann U, Zachmann M, Davajan V, Israel R, Metsman JH, Mishell DR (1976). Male pseudohermaphroditism consistent with 17,20-desmolase deficiency. Gynecol Invest 7:138-156.
23. Campo S, Stivel M, Nicolau G, Monteagudo C, Rivarola M (1979). Testicular function in post-pubertal male pseudohermaphroditism. Clin Endocrinol 11:481-490.
24. Yanase T, Simpson ER, Waterman MR (1991). 17α-Hydroxylase/ 17,20 lyase deficiency: from clinical investigation to molecular definition. Endocr Rev 12:91-108.
25. Yanase T, Waterman MR, Zachmann M, Winter JSD, Simpson ER, Kagimoto M (1992). Molecular basis of apparent isolated 17,20-lyase deficiency: compound heterozygous mutations in the C-terminal region (Arg(496) → Cys, Gln(461) → Stop) actually cause combined 17α-hydroxylase/17,20-lyase deficiency. Biochim Biophys Acta 1139:275-279.
26. Yanase T, Kagimoto M, Suzuki S, Hashiba K, Simpson ER, Waterman MR (1989). Deletion of a phenylalanine in the N-terminal region of human cytochrome P-45017α results in the partial combined 17α-hydroxylase/17,20-lyase deficiency. J Biol Chem 264: 18076-18082.
27. Zachman M, Kenpken B, Manella B, Navarro E (1992). Conversion from pure 17,20 desmolase to combined 17,20-desmolase/17α-hydroxylase deficiency with age. Acta Endocrinol 127:97-99.
28. Kitamura M, Buczko E, Dufau ML (1991). Dissociation of hydroxylase and lyase activities by site-directed mutagenesis of the rat P450-17α. Mol Endocrinol 5:1373-1380.
29. Picado-Leonard J, Miller WL (1988). Homologous sequences in steroidogenic enzymes, steroid receptors and a steroid binding protein suggest a consensus steroid-binding sequence. Mol Endocrinol 2:1145-1150.
30. Lin D, Zhang L, Chiao E, Miller WL (1994). Modeling and mutagenesis of the active site of human P450c17. Mol Endocrinol 8: 392-402.
31. Yanagibashi K, Hall PF (1986). Role of electron transport in the regulation of the lyase activity of C-21 side-chain cleavage P450 from porcine adrenal and testicular microsomes. J Biol Chem 261: 8429-8433.
32. 21 side-chain cleavage). Biochem Biophys Res Commun 108:454-460.
33. 5 potentiation of cytochrome P-450 catalytic activity demonstrated by a vaccinia virus-mediated in situ reconstitution system. Proc Natl Acad Sci USA 87:5425-5429.
34. 5 in adrenal microsomal steroidogenesis. J Steroid Biochem Mol Biol 42:57-64.
35. 5 in the biosynthesis of androgens by human P450c17. Arch Biochem Biophys 317:343-347.
36. 106 and P450 reductase. Endocrinology 132:2498-2506.
37. Grogan J, Shou M, Zhou D, Chen S, Korzekwa KR (1993). Use of aromatase (CYP19) metabolite ratios to characterize electron transfer from NADPH-cytochrome P450 reductase. Biochemistry 32: 12007-12012.
38. Cutler GB, Glenn M, Bush M, Hodgen GD, Graham CE, Loriaux DL (1978). Adrenarche: a survey of rodents, domestic animals and primates. Endocrinology 103:2112-2118.
39. Apter D, Pakarinen A, Hammond GL, Vihko R (1979). Adrenocortical function in puberty. Acta Paediatr Scand 68:599-604.
40. Parker LN, Odell WD (1980). Control of adrenal androgen secretion. Endocr Rev 1:397-410.
41. Sklar CA, Kaplan SL, Grumbach MM (1980). Evidence for dissociation between adrenarche and gonadarche: studies in patients with idiopathic precocious puberty, gonadal dysgenesis, isolated gonadotropin deficiency, and constitutionally delayed growth and adolescence. J Clin Endocrinol Metab 51:548-556.
42. Orentreich N, Brind JL, Rizer RL, Vogelman JH (1984). Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood. J Clin Endocrinol Metab 59:551-555.
43. Parker L, Lifrak E, Shively J, Lee T, Kaplan B, Walker P, Calaycay J, Florsheim W, Soon-Shiong P (1989). Human adrenal gland cortical androgen-stimulating hormone (CASH) is identical with a portion of the joining peptide of pituitary pro-opiomelanocortin (POMC). 71st Annual Meeting of the Endocrine Society. Abstract 299.
44. Mellon SH, Shively JE, Miller WL (1991). Human proopiomelanocortin (79-96), a proposed androgen stimulatory hormone, does not affect steroidogenesis in cultured human fetal adrenal cells. J Clin Endocrinol Metab 72:19-22.
45. Penhoat A, Sanchez P, Jaillard C, Langlois D, Begeot M, Saez JM (1991). Human proopiomelanocortin (79-96), a proposed cortical androgen stimulating hormone, does not affect steroidogenesis in cultured human adult adrenal cells. J Clin Endocrinol Metab 72: 23-26.
46. Robinson P, Bateman A, Mulay S, Spencer SJ, Jaffe RB, Solomon S, Bennett HPJ (1991). Isolation and characterization of three forms of joining peptide from adult pituitaries: lack of adrenal androgen stimulating activity. Endocrinology 129:859-867.
47. Couch RM, Muller J, Winter JSD (1986). Regulation of the activities of 17α-hydroxylase and 17,20-desmolase in the human adrenal cortex: kinetic analysis and inhibition by endogenous steroids. J Clin Endocrinol Metab 63:613-618.
48. Liu C, Laughlin GA, Fischer VG, Yen SSC (1990). Marked attenuation of ultradian and circadian rhythms of dehydroepiandrosterone in postmenopausal women: evidence for a reduced 17,20-demolase enzymatic activity. J Clin Endocrinol Metab 71:900-906.
49. Zhang L, Rodriguez H, Ohno S, Miller WL (1995). Serine phosphorylation of human P450c17 increases 17,20 lyase activity: implications for adrenarche and for the polycystic ovary syndrome. Proc Natl Acad Sci USA 92:10619-10623.
50. 489 in human cytochrome P450c17 causes severe 17α-hydroxylase deficiency. J Clin Endocrinol Metab 77:489-493.
51. Gazdar AF, Oie HK, Shackleton CH, Chen TR, Triche TJ, Myers CE, Chrousos GP, Brennan MF, Stein CA, LaRocca RV (1990). Establishment and characterization of a human adrenocortical carcinoma cell line that expresses multiple pathways of steroid biosynthesis. Cancer Res 50:5488-5496.
52. Staels B, Hum DW, Miller WL (1993). Regulation of steroidogenesis in NCI-H295 cells: a cellular model of the human fetal adrenal. Mol Endocrinol 7:423-433.
53. Maurer RA (1989). Both isoforms of the cAMP-dependent protein kinase catalytic subunit can activate transcription of the prolactin gene. J Biol Chem 264:6870-6873.
54. Barnes HJ, Arlotto MP, Waterman MR (1991). Expression and enzymatic activity of recombinant cytochrome P450 17α-hydroxylase in E. coli. Proc Natl Acad Sci USA 88:5597-5601.
55. Poulos TL, Finzel BC, Howard AJ (1987). High-resolution crystal structure of cytochrome P450cam. J Mol Biol 195:687-700.
56. CAM ternary complex. Biochemistry 28: 7586-7592.
57. Nebert DW, Gonzalez FJ (1987). P450 genes: structure, evolution and regulation. Annu Rev Biochem 56:945-993.
58. Black SD, Coon MJ (1987). P-450 cytochromes: structure and function. Adv Enzymol Relat Areas Mol Biol 60:35-87.
59. Gonzalez FJ (1989). The molecular biology of cytochrome P450s. Pharmacol Rev 40:243-288.
60. Nelson DR, Strobel HW (1989). Secondary structure predictions of 52 membrane-bound cytochromes P450 shows a strong structural similarity to P450 cam. Biochemistry 28:656-660.
61. Nelson DR, Strobel HW (1988). On the membrane topology of vertebrate cytochrome P450 proteins. J Biol Chem 263:6038-6050.
62. Kalb VF, Loper JC (1988). Proteins from eight eukaryotic cytochrome P-450 families shared a segmented region of sequence similarity. Proc Natl Acad Sci USA 85:7221-7225.
63. Edwards RJ, Murray BP, Boobis AR, Davies DS (1989). Identification and location of a-helices in mammalian cytochromes P450. Biochemistry 28:3762-3770.
64. Ferrin TE, Huang CC, Jarvis LE, Langridge R (1988). The MIDAS database system. J Mol Graphics 6:2-12.
65. Ferrin TE, Huang CC, Jarvis LE, Langridge R (1988). The MIDAS display system. J Mol Graphics 6:13-27.
66. Laughton CA, Neidle S, Zvelebil MJJM, Sternberg MJ (1990). A molecular model for the enzyme cytochrome P450-17α a major target for the chemotherapy of prostatic cancer. Biochem Biophys Res Commun 171:1160-1167.
67. Ponder JW, Richards FM (1987). Tertiary templates for proteins: use of packing criteria in the enumeration of allowed sequences for different structural classes. J Mol Biol 193:775-791.
68. Summers NL, Karplus M (1989). Construction of side-chains in homology modelling: application to the c-terminal lobe of rhizopuspepsin. J Mol Biol 210:785-811.
69. Des Jarlais R, Sheridan RP, Seibel GL, Dixon JS, Kuntz ID, Venkataraghavan R (1988). Using shape complementarity as an initial screen in designing ligands for a receptor binding site of known three-dimensional structure. J Med Chem 31:722-729.
70. Ravichandran KG, Boddupalli SS, Hasemann CA, Peterson JA, Deisenhofer J (1993). Crystal structure of hemoprotein domain of P450BM-3, a prototype for microsomal P450's. Science 261:731-736.
71. Hasemann CA, Ravichandran KG, Peterson JA, Deisenhofer J (1994). Crystal structure and refinement of cytochrome P450terp at 2.3 Å resolution. J Mol Biol 236:1169-1185.
72. Cupp-Vickery JR, Poulos TL (1995). Structure of cytochrome P450eryF involved in erythromycin biosynthesis. Struct Biol 2:144-153.
73. Fulco AJ (1991). P450BM-3 and other inducible bacterial P450 cytochromes: biochemistry and regulation. Annu Rev Pharmacol Toxicol 31:177-203.
74. Hasemann CA, Kurumbail RG, Boddupalli SS, Peterson JA, Deisenhofer J (1995). Structure and function of cytochromes P450: a comparative analysis of three crystal structures. Structure 3:41-62.
75. Graham-Lorence S, Amarneh B, White RE, Peterson JA, Simpson ER (1995). A three-dimensional model of aromatase cytochrome P450. Protein Sci 4:1065-1080.
76. Auchus RJ, Graham-Lorence S, Peterson JB, Miller WL (1996). A second-generation molecular graphics model of human P450c17 based on assembly of core structures. 2nd International Symposium on Molecular Steroidogenesis, Monterey, CA. Abstract P-36.
77. Geller DH, Mendonça BB, Miller WL (1996). The molecular basis of isolated 17,20 lyase deficiency. Pediatric Res. 39:89A (Abstract 519).